Tag: Food and Drug Administration (FDA)

Recommended Reading: New Empirical Analysis of False Claims Act Whistleblower Litigation

Filed in Recommended Reading by on January 23, 2015 0 Comments
Recommended Reading: New Empirical Analysis of False Claims Act Whistleblower Litigation

By Kate Greenwood Cross-Posted at Bill of Health Late last year, the Columbia Law Review published David Freeman Engstrom’s Private Enforcement’s Pathways: Lessons from Qui Tam Litigation, the fourth in a series of articles Professor Engstrom has written on the growth and evolution of qui tam litigation. (My colleague Associate Dean Kathleen Boozang wrote about […]

Continue Reading »

Monday Morning Recap: The Week (5.26.14-6.1.14) in Drug & Device Law & Policy

Filed in Monday Morning Recap by on June 2, 2014 0 Comments
Monday Morning Recap: The Week (5.26.14-6.1.14) in Drug & Device Law & Policy

Here’s this week’s Monday Morning Recap, the post where we call out the drug and device law and policy developments that caught our eye and made us think over the previous week.  You can see all of our previous Monday Morning Recap posts here. Credit for the format goes to Seton Hall Law alum Jordan […]

Continue Reading »

Monday Morning Recap: The Week (4.21.14-4.27.14) in Drug & Device Law & Policy

Filed in Monday Morning Recap by on April 28, 2014 2 Comments
Monday Morning Recap: The Week (4.21.14-4.27.14) in Drug & Device Law & Policy

What follows is a weekly feature here at Health Reform Watch.  Each Monday, we provide a recap of the drug and device law and policy developments over the previous week that caught our eye and made us think.  Credit for the format goes to Seton Hall Law alum Jordan T. Cohen, who used it to […]

Continue Reading »

Monday Morning Recap: The Week (2.17.14-2.23.14)) in Drug & Device Law & Policy

Filed in Monday Morning Recap by on February 24, 2014 0 Comments
Monday Morning Recap: The Week (2.17.14-2.23.14)) in Drug & Device Law & Policy

What follows is a weekly feature here at Health Reform Watch.  Each Monday, we provide a recap of the drug and device law and policy developments over the previous week that caught our eye and made us think.  Credit for the format goes to Seton Hall Law alum Jordan T. Cohen, who used it to […]

Continue Reading »

Monday Morning Recap: The Week (1.27.14-2.2.14) in Drug & Device Law & Policy

Filed in Monday Morning Recap by on February 3, 2014 0 Comments
Monday Morning Recap: The Week (1.27.14-2.2.14) in Drug & Device Law & Policy

What follows is a weekly feature here at Health Reform Watch.  Each Monday, we provide a recap of the drug and device law and policy developments over the previous week that caught our eye and made us think.  Credit for the format goes to Seton Hall Law alum Jordan T. Cohen, who used it to […]

Continue Reading »